| MicroRNA-223 suppresses the canonical NF-κB pathway in basal keratinocytes to dampen neutrophilic inflammation W Zhou, AS Pal, AYH Hsu, T Gurol, X Zhu, SE Wirbisky-Hershberger, ... Cell reports 22 (7), 1810-1823, 2018 | 118 | 2018 |
| Animal models to study microRNA function AS Pal, AL Kasinski Advances in cancer research 135, 53-118, 2017 | 70 | 2017 |
| Cigarette smoke condensate promotes pro‐tumourigenic stromal–epithelial interactions by suppressing miR‐145 A Pal, G Melling, EE Hinsley, TD Kabir, HE Colley, C Murdoch, ... Journal of oral pathology & medicine 42 (4), 309-314, 2013 | 36 | 2013 |
| Identification of microRNAs that promote erlotinib resistance in non-small cell lung cancer AS Pal, M Bains, A Agredo, AL Kasinski Biochemical pharmacology 189, 114154, 2021 | 28 | 2021 |
| Loss of KMT5C promotes EGFR inhibitor resistance in NSCLC via LINC01510-mediated upregulation of MET AS Pal, A Agredo, NA Lanman, J Son, IS Sohal, M Bains, C Li, ... Cancer research 82 (8), 1534-1547, 2022 | 25 | 2022 |
| Loss of SUV420H2 promotes EGFR inhibitor resistance in NSCLC through upregulation of MET via LINC01510 AS Pal, AM Agredo, NA Lanman, J Clingerman, K Gates, AL Kasinski BioRxiv, 2020.03. 17.995951, 2020 | 3 | 2020 |
| Loss of the methyltransferase KMT5C drives resistance to tyrosine kinase inhibitors via H4K20me3 regulation in non-small cell lung cancer A Agredo, A Pal, J Son, NA Lanman, AL Kasinski Cancer Research 83 (7_Supplement), 4752-4752, 2023 | 1 | 2023 |
| In-Cell Western Protocol for Semi-High-Throughput Screening of Single Clones AS Pal, AM Agredo, AL Kasinski Bio-protocol 12 (16), e4489-e4489, 2022 | 1 | 2022 |
| Aberrantly expressed microRNAs drive the development of acquired Erlotinib resistance in non-small cell lung cancer AS Pal, A Agredo, AL Kasinski Cancer Research 77 (13_Supplement), 3142-3142, 2017 | 1 | 2017 |
| A GPRC5D and BCMA bispecific CAR-T product demonstrated dual antigen targeting capability and efficacy against multiple myeloma cells bearing BCMA mutations associated with … W Chang, C.-W., Luo, Y., Pal, A.S., Ding, H., Lai, Y.-S., Guan, S., Lan, W., Li Journal for ImmunoTherapy of Cancer 12, A284, 2024 | | 2024 |
| Loss of SUV420H2 drives EGFR inhibitor resistance in EGFR mutant NSCLC cell lines A Agredo, A Pal, N Lanman, J Son, AL Kasinski Cancer Research 82 (12_Supplement), 1104-1104, 2022 | | 2022 |
| Identification of novel epigenetic mediators of erlotinib resistance in non-small cell lung cancer AS Pal Purdue University, 2020 | | 2020 |
| Suppression of NF‐κB Activation in Basal Keratinocytes Via Cell Autonomous and Non‐Autonomous Functions of MicroRNA‐223 W Zhou, AYH Hsu, T Gurol, X Zhu, SE Wirbisky, AS Pal, AL Kasinski, ... Available at SSRN 3155596, 2018 | | 2018 |
